Table 2.
Human cell-line and tissue specificity
| Cell lLine | Human tissue (pathology) | Titer (LSU/ml) |
|---|---|---|
| Caki-1 | Kidney (carcinoma) | 2.1 ± 1.6 × 103 |
| Caki-2 | Kidney (carcinoma) | <10 |
| A498 | Kidney (carcinoma) | 7.7 ± 1.5 × 103 |
| ACHN | Kidney (carcinoma) | 3.9 ± 3.8 × 102 |
| 293T | Kidney (normal) | 4.0 ± 2.0 × 105 |
| TE671 | Muscle (rhabdomyosarcoma) | 2.5 ± 1.3 × 105 |
| 143B | Bone (osteosarcoma) | 1.4 ± 0.5 × 105 |
| 1.3 ± 0.3 × 108a | ||
| HOS (CRL1543) | Bone (osteosarcoma) | 8.9 ± 0.9 × 104 |
| MG63 (CRL1427) | Bone (osteosarcoma) | 2.2 ± 0.2 × 105 |
| HeLa | Cervix (carcinoma) | 1.6 ± 1.3 × 105 |
| HepG2 | Liver (carcinoma) | 3.5 ± 2.9 × 105 |
| Huh-7 | Liver (carcinoma) | 2.0 ± 0.9 × 104 |
| DLD-1 | Colon (carcinoma) | 8.3 ± 6.9 × 103 |
| PC3 | Prostate (metastatic carcinoma) | 2.7 ± 1.5 × 104 |
| DU-145 | Prostate (carcinoma) | 7.0 ± 4.7 × 101 |
| HFF | Foreskin fibroblasts (normal) | 5.1 ± 1.8 × 103 |
aVirus stock concentrated 56-fold by centrifugation.